Chalkis Health Industry Co., Ltd. Class A

As of June 30, 2026, Chalkis Health Industry Co., Ltd. Class A carries a market capitalization of 2.41B, placing it among publicly traded companies globally. Its enterprise value stands at 2.67B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Chalkis Health Industry Co., Ltd. Class A has 771.28M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Chalkis Health Industry Co., Ltd. Class A maintains a current ratio of 0.64, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026. Inventory turnover of 1.25 indicates how many times Chalkis Health Industry Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Chalkis Health Industry Co., Ltd. Class A recorded 253,966.79 in income tax expense.

As of the close on October 23, 2026, Chalkis Health Industry Co., Ltd. Class A's stock has gained approximately 4.37% over the past 52 weeks. The 50-day moving average sits at 3.86, while the 200-day moving average is 3.73.

These figures cover the twelve months ended June 30, 2026.

As of June 30, 2026, Chalkis Health Industry Co., Ltd. Class A holds 300.62M in cash and equivalents against 554.31M in total debt, resulting in a net debt position of 206.61M. Total book value stands at -39.80M, with working capital of -311.81M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Chalkis Health Industry Co., Ltd. Class A paid dividends of 0.01 per share.

Chalkis Health Industry Co., Ltd. Class A's most recent stock split took place on February 22, 2013 with a 5:8 split ratio.